Yellen was criticized a few months back for opining on the strength of biotech and social media stocks. Those stocks got hit for a day, but then stormed back to make more highs. Yellen learned from her mistake and has gone quietly into the good night with regard to market predictions. She continues to be as dovish as ever though, […]
We hate to spoil the surprise, but the answer, as clearly shown by the first blue bar on the chart below, is Energy, and specifically the ridiculous valuation that energy companies are currently trading at. Why? Because as the following Factset chart shows, the forward P/E of the energy sector is currently 27x – an all time high – and […]
The stock has even more upside from where it was trading Friday, around $475 per share, Yaron Werber, senior biotech analyst at Citi Investment Research, told “Power Lunch.” As the Alzheimer’s drug likely will not reach the market for years, it is important to Biogen’s long-term prospects, he said.When looking at valuations, investors need to consider that low interest rates […]
The stock has even more upside from where it was trading Friday, around $475 per share, Yaron Werber, senior biotech analyst at Citi Investment Research, told “Power Lunch.” As the Alzheimer’s drug likely will not reach the market for years, it is important to Biogen’s long-term prospects, he said.When looking at valuations, investors need to consider that low interest rates […]
The stock has even more upside from where it was trading Friday, around $475 per share, Yaron Werber, senior biotech analyst at Citi Investment Research, told “Power Lunch.” As the Alzheimer’s drug likely will not reach the market for years, it is important to Biogen’s long-term prospects, he said.When looking at valuations, investors need to consider that low interest rates […]
Related 13 Management Changes That Happened This Week8-K Filing Shows Bind Therapeutics Closes Offering Of StockRelated Morning Market LosersCerulean Announces Completion of Enrollment of a Phase 1b/2 Study of CRLX101 in Combination with Avastin® in Relapsed Renal Cell CarcinomaCerulean Pharma (CERU) Shares March Higher, Can It Continue? – Tale of the Tape(Zacks)In a recent report, analysts at JMP Securities discussed […]
In a recent report, analysts at JMP Securities discussed five biotech names that are on their radar. Here’s a breakdown of what they had to say.
BIND Therapeutics Inc (NASDAQ: BIND)
BIND will be presenting three posters on its Accurin technology at the American Association of Cancer Research (AACR) meeting in Philadelphia in April.Although the Accurin data the company will be showcasing […]
BloombergThe iShares Nasdaq Biotechnology ETF over 12 months
Stocks sold off on Thursday after a post-Fed rally on Wednesday.
But the Nasdaq still gained ground thanks to the biotech sector which gained about 2% on Thursday. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last month, Max Nisen at Quartz wrote that while everyone is focusing on […]
* Energy shares lower on dollar strength, oversupply concern* Guess posts strong quarterly earnings, shares rally* Indexes: Dow off 0.6 pct, S&P off 0.5 pct, Nasdaq up 0.2 pct (Updates prices, changes comment, byline)By Rodrigo CamposNEW YORK, March 19 (Reuters) – U.S. stocks fell on Thursday as a stronger dollar weighed on oil and other commodity prices, with energy and […]
CORAL GABLES, FL / ACCESSWIRE / March 19, 2015 / BiotechStocks.com, an online destination for the burgeoning biotechnology sector focused on information concerning biotech stocks is proud to announce that after several months in development, the Company’s online destination has been fully optimized with live media and exclusive articles on biotech companies and biotech stocks.The biotech industry encompasses a wide […]
